Thomas Eisiminger

Thomas Eisiminger

Director Ejecutivo en Regenesis Biomedical, Inc. .

Consumer Services
Commercial Services
Health Technology

Perfil

Thomas Eisiminger is currently the President, Chief Executive Officer & Director at Regenesis Biomedical, Inc. He is also a Member of the Veterans of Foreign Wars of the United States, Disabled American Veterans, Inc., and The American Legion (Connecticut).
Previously, he worked as a Director at the American Diabetes Association, a Lieutenant Colonel in The United States Army (District of Columbia), and a Principal at GlaxoSmithKline LLC.
He holds an MBA from Marylhurst University, an undergraduate degree from the US Military Academy (conferred in 1984), and a graduate degree from the Naval War College.

Cargos activos de Thomas Eisiminger

EmpresasCargoInicio
Director Ejecutivo 11/01/2021
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Todos los cargos activos de Thomas Eisiminger

Antiguos cargos conocidos de Thomas Eisiminger.

EmpresasCargoFin
Corporate Officer/Principal -
Director/Miembro de la Junta -
The United States Army (District of Columbia) Corporate Officer/Principal -
Ver el detalle de la experiencia de Thomas Eisiminger.

Formación de Thomas Eisiminger.

Marylhurst University Masters Business Admin
Naval War College Graduate Degree
US Military Academy Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Thomas Eisiminger.

Relaciones

100 +

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas7

Health Technology

The United States Army (District of Columbia)

Government

Health Technology

Commercial Services

Health Services

Commercial Services

Commercial Services

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Thomas Eisiminger
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA